CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253,314,338 | +22.3% | 9,297,645 | -0.1% | 0.01% | +20.0% |
| Q2 2023 | $207,174,756 | -8.3% | 9,311,225 | -10.8% | 0.01% | -16.7% |
| Q1 2023 | $226,016,556 | +7.6% | 10,434,744 | +0.9% | 0.01% | 0.0% |
| Q4 2022 | $210,107,560 | -20.7% | 10,345,030 | +0.1% | 0.01% | -25.0% |
| Q3 2022 | $264,915,000 | +12.8% | 10,332,077 | +4.6% | 0.01% | +14.3% |
| Q2 2022 | $234,796,000 | -0.1% | 9,873,663 | -5.4% | 0.01% | +16.7% |
| Q1 2022 | $235,081,000 | +10.0% | 10,438,752 | -3.3% | 0.01% | +20.0% |
| Q4 2021 | $213,790,000 | -8.5% | 10,797,477 | -9.0% | 0.01% | -16.7% |
| Q3 2021 | $233,612,000 | -11.3% | 11,870,518 | -0.9% | 0.01% | -14.3% |
| Q2 2021 | $263,502,000 | -10.6% | 11,977,384 | -3.3% | 0.01% | -12.5% |
| Q1 2021 | $294,704,000 | -6.1% | 12,387,727 | +3.3% | 0.01% | -11.1% |
| Q4 2020 | $313,819,000 | +53.7% | 11,996,149 | +2.3% | 0.01% | +28.6% |
| Q3 2020 | $204,192,000 | +8.0% | 11,731,804 | +4.4% | 0.01% | 0.0% |
| Q2 2020 | $189,045,000 | +43.0% | 11,239,346 | +1.1% | 0.01% | +16.7% |
| Q1 2020 | $132,191,000 | -0.2% | 11,117,827 | +1.5% | 0.01% | +20.0% |
| Q4 2019 | $132,479,000 | -14.1% | 10,948,746 | +0.4% | 0.01% | -16.7% |
| Q3 2019 | $154,166,000 | +26.3% | 10,906,661 | -0.4% | 0.01% | +20.0% |
| Q2 2019 | $122,072,000 | -4.9% | 10,948,119 | +0.1% | 0.01% | 0.0% |
| Q1 2019 | $128,383,000 | -10.8% | 10,935,561 | +1.5% | 0.01% | -16.7% |
| Q4 2018 | $143,940,000 | -0.9% | 10,773,994 | +4.0% | 0.01% | 0.0% |
| Q3 2018 | $145,283,000 | -10.5% | 10,362,560 | +0.4% | 0.01% | -14.3% |
| Q2 2018 | $162,306,000 | +12.7% | 10,324,779 | +18.0% | 0.01% | +16.7% |
| Q1 2018 | $143,958,000 | -14.9% | 8,751,268 | -6.6% | 0.01% | -14.3% |
| Q4 2017 | $169,226,000 | +40.6% | 9,370,179 | +50.3% | 0.01% | +16.7% |
| Q3 2017 | $120,348,000 | +129.7% | 6,235,579 | +40.4% | 0.01% | +100.0% |
| Q2 2017 | $52,394,000 | +27.5% | 4,440,064 | +18.4% | 0.00% | +50.0% |
| Q1 2017 | $41,106,000 | +67.0% | 3,750,510 | +10.6% | 0.00% | +100.0% |
| Q4 2016 | $24,620,000 | +22.8% | 3,391,333 | +10.0% | 0.00% | 0.0% |
| Q3 2016 | $20,044,000 | +23.2% | 3,083,764 | +3.5% | 0.00% | 0.0% |
| Q2 2016 | $16,269,000 | +24.8% | 2,979,735 | +7.0% | 0.00% | 0.0% |
| Q1 2016 | $13,039,000 | -5.1% | 2,786,006 | +0.9% | 0.00% | 0.0% |
| Q4 2015 | $13,746,000 | -92.3% | 2,760,309 | -72.0% | 0.00% | -85.7% |
| Q3 2015 | $178,732,000 | +1031.8% | 9,842,232 | +274.6% | 0.01% | +600.0% |
| Q2 2015 | $15,792,000 | +25.4% | 2,627,587 | +16.8% | 0.00% | 0.0% |
| Q1 2015 | $12,596,000 | +90.6% | 2,249,383 | +2.1% | 0.00% | – |
| Q4 2014 | $6,607,000 | +14.3% | 2,202,296 | +2.1% | 0.00% | – |
| Q3 2014 | $5,780,000 | -3.9% | 2,156,883 | +0.4% | 0.00% | – |
| Q2 2014 | $6,016,000 | -35.2% | 2,148,244 | +0.9% | 0.00% | -100.0% |
| Q1 2014 | $9,284,000 | +51.3% | 2,129,395 | +11.7% | 0.00% | 0.0% |
| Q4 2013 | $6,138,000 | +92.9% | 1,906,451 | -4.7% | 0.00% | – |
| Q3 2013 | $3,182,000 | -7.1% | 2,000,958 | +1.0% | 0.00% | – |
| Q2 2013 | $3,427,000 | – | 1,980,774 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |